Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary shares, nominal value 0.0025 per share
-
Shares outstanding
-
328,915,843
-
Total 13F shares
-
630,301
-
Share change
-
+103,728
-
Total reported value
-
$4,172,000
-
Price per share
-
$6.55
-
Number of holders
-
3
-
Value change
-
+$689,920
-
Number of buys
-
2
Institutional Holders of Renalytix plc - Ordinary shares, nominal value 0.0025 per share as of Q2 2020
As of 30 Jun 2020,
Renalytix plc - Ordinary shares, nominal value 0.0025 per share was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
630,301 shares.
The largest 3 holders included
GILDER GAGNON HOWE & CO LLC, GOFEN & GLOSSBERG LLC /IL/, and TIAA, FSB.
This page lists
3
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.